Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.35 -0.06 (-0.04%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Why Johnson & Johnson Stock Is Moving Higher After Hours
Johnson & Johnson (NYSE: JNJ) shares are trading higher in Tuesday's after-hours session after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder... 
Via Benzinga
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts. 
Via The Motley Fool
This Is What Whales Are Betting On Johnson & Johnson
 
Via Benzinga
3 Top Healthcare Stocks to Buy for April
These pharmaceutical companies' shares are down, but their prospects are rising. 
Via The Motley Fool
3 Dow Stocks That Are Screaming Buys in April
Among the Dow Jones Industrial Average's 30 components, there are three plain-as-day bargains. 
Via The Motley Fool
9 Upcoming Dividend Increases In April 2023
April is going to be a huge month of dividend increases. 
Via Talk Markets
Peering Into Johnson & Johnson's Recent Short Interest
 
Via Benzinga
Analyst Expectations for Johnson & Johnson's Future
 
Via Benzinga
Johnson & Johnson Unusual Options Activity
 
Via Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
These blue chips are down. Is it time to buy? 
Via The Motley Fool
3 Dow Stocks With Above-Average Dividends Yields to Buy in April
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now. 
Via The Motley Fool
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now
Now's a great time to buy some shares of these highly reliable dividend-payers. 
Via The Motley Fool
3 Warren Buffett Stocks That Are No-Brainer Buys in April
Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now. 
Via The Motley Fool
Could This Move by Johnson & Johnson Equal Billions for Moderna?
An RSV vaccine could be a driver of blockbuster revenue. 
Via The Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
These drugmakers could deliver greater gains than many investors expect. 
Via The Motley Fool
3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio
Income-based portfolios can steady the ship when volatility spikes. Let's look at a few dividend stocks to buy right now. 
Via InvestorPlace
11 Stocks: 9 Dividend Payers 2 For Growth
Not all stocks are the same, and not all stocks serve the investor’s needs. 
Via Talk Markets
The 3 Best Stocks to Buy if You Want to Retire Early
The best stocks for early retirement strike a good balance between long-term growth and reliable security. 
Via InvestorPlace
2 Unstoppable Stocks to Buy Without Hesitation Right Now
These industry giants are going from strength to strength in a volatile market. 
Via The Motley Fool
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
 
Via Benzinga
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
The company says it's refocusing its portfolio to focus on transformational medicines. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
 
Via Benzinga
Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows
Both of these stocks also provide investors with attractive dividend yields of around 3%. 
Via The Motley Fool
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
Curious about the "dogs of the Dow" in 2023? Here's what's happening in the darkest corner of Wall Street's most exclusive club. 
Via The Motley Fool
Top 5 "Forever" Stocks To Buy In 2023
Would you like to know about ultra-high-quality dividend growth stocks that could be considered 
Via Talk Markets
7 Dividend Aristocrats to Buy for Consistent Income Growth
The dividend aristocrats each provide consistent income growth over the long-term that those seeking passive income can rely on. 
Via InvestorPlace
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner. 
Via The Motley Fool
It's a Mistake to Ignore the Growth Potential of These 3 Dividend Stocks
Coca-Cola, J&J, and IBM are still solid long-term income investments. 
Via The Motley Fool
3 Blue-Chip Stocks to Buy for Stability and Safety
While there’s no such thing as 100% safe blue-chip stocks, these three are better than most when seeking to preserve capital. 
Via InvestorPlace
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
Impact Biomedical, a biotechnology company focused on developing innovative treatments for a wide range of diseases and conditions and one of the key businesses in the DSS Inc. (NYSE American: DSS)... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.